Aptus Pharma Limited
Aptus Pharma Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under BSE: 544529 (ISIN INE15XJ01010).
It has a market capitalisation of ₹827 crore, a last close of ₹482.10 on 2026-10-19, a one-year return of 272.2%.
Valuation: a price-to-earnings ratio of 179x, a price-to-book ratio of 35.41x.
Profitability: return on equity of 19.8%, return on capital employed of 29.6%, an operating margin of 16.0%.
Balance sheet and ownership: debt-to-equity of 0.31x, promoter holding of 72.9%.
| Metric | Value |
|---|---|
| Market capitalisation | 827 |
| Last close | ₹482.10 |
| P/E (TTM) | 179x |
| P/B | 35.41x |
| ROE (FY) | 19.8% |
| ROCE (FY) | 29.6% |
| Operating margin (TTM) | 16.0% |
| Debt / equity | 0.31x |
| Promoter holding | 72.9% |
| 1-year return | 272.2% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means